Healthcare Tech Giant Claritev Poaches Top Oracle Medical Chief and Merck AI Leader for Digital Revolution – Stock Titan

Lockheed Martin Announces Chief Financial Officer Transition
Chagee Holdings Limited Announces Pricing of Initial Public Offer…
uniQure Announces FDA Breakthrough Therapy Designation Granted to…
Anthropic Joins Palantir’s FedStart Program to Deploy Claude Appl…
Global Payments Announces Agreements to Acquire Worldpay and Dive…
Tilray Brands Announces Proposed Reverse Stock Split and Correspo…
Lockheed Martin Announces Chief Financial Officer Transition
Chagee Holdings Limited Announces Pricing of Initial Public Offer…
uniQure Announces FDA Breakthrough Therapy Designation Granted to…
Anthropic Joins Palantir’s FedStart Program to Deploy Claude Appl…
Global Payments Announces Agreements to Acquire Worldpay and Dive…
Tilray Brands Announces Proposed Reverse Stock Split and Correspo…
Claritev (NYSE: CTEV) has announced two key appointments to strengthen its leadership team as part of its business transformation strategy. Dr. Jigar S. Patel will join as Chief Medical Officer effective April 14, 2025, bringing over 18 years of experience from Cerner/Oracle. He will provide medical guidance on strategic development and product innovation of Claritev’s healthcare technology solutions.
Dr. Fernando Schwartz has been appointed as Chief Artificial Intelligence Officer, effective February 17, 2025. With 15 years of leadership in data science and machine learning, Schwartz previously served as VP of AI at ADP and led global data science strategy at Merck’s Human Health Division. He will lead the company’s AI and analytics strategy under Chief Digital Officer Michael Kim.
Claritev (NYSE: CTEV) ha annunciato due nomine chiave per rafforzare il proprio team dirigenziale nell’ambito della strategia di trasformazione aziendale. Il Dott. Jigar S. Patel entrerà in carica come Chief Medical Officer a partire dal 14 aprile 2025, portando con sé oltre 18 anni di esperienza maturata in Cerner/Oracle. Fornirà consulenza medica per lo sviluppo strategico e l’innovazione dei prodotti nelle soluzioni tecnologiche sanitarie di Claritev.
Il Dott. Fernando Schwartz è stato nominato Chief Artificial Intelligence Officer, con effetto dal 17 febbraio 2025. Con 15 anni di esperienza nella leadership in data science e apprendimento automatico, Schwartz è stato in precedenza VP di AI presso ADP e ha guidato la strategia globale di data science nella divisione Human Health di Merck. Dirigerà la strategia di AI e analisi dell’azienda sotto la supervisione del Chief Digital Officer Michael Kim.
Claritev (NYSE: CTEV) ha anunciado dos nombramientos clave para fortalecer su equipo directivo como parte de su estrategia de transformación empresarial. El Dr. Jigar S. Patel se incorporará como Chief Medical Officer a partir del 14 de abril de 2025, aportando más de 18 años de experiencia en Cerner/Oracle. Brindará asesoramiento médico en el desarrollo estratégico e innovación de productos en las soluciones tecnológicas de salud de Claritev.
El Dr. Fernando Schwartz ha sido nombrado Chief Artificial Intelligence Officer, con efecto desde el 17 de febrero de 2025. Con 15 años de liderazgo en ciencia de datos y aprendizaje automático, Schwartz fue anteriormente vicepresidente de IA en ADP y lideró la estrategia global de ciencia de datos en la división Human Health de Merck. Dirigirá la estrategia de IA y análisis de la empresa bajo la supervisión del Chief Digital Officer Michael Kim.
Claritev (NYSE: CTEV)는 비즈니스 혁신 전략의 일환으로 리더십 팀 강화를 위해 두 명의 핵심 임원을 임명했다고 발표했습니다. Jigar S. Patel 박사는 2025년 4월 14일부터 최고 의료 책임자(Chief Medical Officer)로 합류하며, Cerner/Oracle에서 18년 이상의 경력을 보유하고 있습니다. 그는 Claritev의 헬스케어 기술 솔루션의 전략 개발 및 제품 혁신에 의료 자문을 제공할 예정입니다.
Fernando Schwartz 박사는 2025년 2월 17일부터 최고 인공지능 책임자(Chief Artificial Intelligence Officer)로 임명되었습니다. 데이터 과학 및 머신러닝 분야에서 15년간 리더십을 발휘한 그는 이전에 ADP에서 AI 부사장을 역임했으며, Merck의 Human Health 부문에서 글로벌 데이터 과학 전략을 이끌었습니다. 그는 최고 디지털 책임자 마이클 김(Michael Kim) 아래에서 회사의 AI 및 분석 전략을 이끌 것입니다.
Claritev (NYSE : CTEV) a annoncé deux nominations clés pour renforcer son équipe de direction dans le cadre de sa stratégie de transformation commerciale. Le Dr Jigar S. Patel rejoindra l’entreprise en tant que Chief Medical Officer à compter du 14 avril 2025, apportant plus de 18 ans d’expérience chez Cerner/Oracle. Il apportera son expertise médicale pour le développement stratégique et l’innovation des produits des solutions technologiques de santé de Claritev.
Le Dr Fernando Schwartz a été nommé Chief Artificial Intelligence Officer, à compter du 17 février 2025. Avec 15 ans d’expérience en leadership dans la science des données et l’apprentissage automatique, Schwartz a précédemment été VP de l’IA chez ADP et a dirigé la stratégie mondiale de science des données chez Merck, division Human Health. Il dirigera la stratégie IA et analytique de l’entreprise sous la direction du Chief Digital Officer Michael Kim.
Claritev (NYSE: CTEV) hat zwei wichtige Ernennungen bekannt gegeben, um sein Führungsteam im Rahmen seiner Unternehmensumwandlungsstrategie zu stärken. Dr. Jigar S. Patel wird ab dem 14. April 2025 als Chief Medical Officer eintreten und bringt über 18 Jahre Erfahrung von Cerner/Oracle mit. Er wird medizinische Beratung zur strategischen Entwicklung und Produktinnovation der Gesundheits-technologielösungen von Claritev bieten.
Dr. Fernando Schwartz wurde zum Chief Artificial Intelligence Officer ernannt, mit Wirkung zum 17. Februar 2025. Mit 15 Jahren Führungserfahrung in Data Science und maschinellem Lernen war Schwartz zuvor VP für KI bei ADP und leitete die globale Data-Science-Strategie in der Human Health Division von Merck. Er wird die KI- und Analyse-Strategie des Unternehmens unter der Leitung des Chief Digital Officer Michael Kim führen.
Jigar S. Patel, MD, Named Chief Medical Officer
Fernando Schwartz, Ph.D., Named Chief Artificial Intelligence Officer
MCLEAN, Va.–(BUSINESS WIRE)– Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the following newly created appointments to its senior leadership team to support the company’s strategic growth, transformation and mission to bring transparency to the healthcare ecosystem with innovative products and solutions.
Jigar S. Patel, MD, has been appointed Chief Medical Officer effective April 14, 2025. As a new member of the Executive Leadership Team, Patel will provide medical guidance on the strategic development and product innovation of Claritev’s healthcare technology and network optimization solutions. Patel brings deep expertise in healthcare delivery, medical network dynamics and industry relationships. This experience will be integral as he works to align Claritev’s products with the evolving needs of the industry, including health plans, payors and other medical organizations. Prior to joining Claritev, Patel spent more than 18 years at Cerner/Oracle where he worked with large national healthcare companies on all aspects of their Healthcare Information Technology needs and strategy.
Fernando Schwartz, Ph.D., has been appointed Chief Artificial Intelligence Officer effective February 17, 2025. Schwartz leads the AI and Data Science Department on Chief Digital Officer Michael Kim’s team. Bringing 15 years of leadership in data science and machine learning, Schwartz will lead the Company’s AI and analytics strategy as well as new product development and capabilities that will benefit existing and new clients or partners. Prior to joining Claritev, Schwartz most recently served as the Vice President of AI at ADP. Before that, he led the global data science strategy for Merck’s Human Health Division as the Associate Vice President and Global Head of Data Science.
“Today’s announcement marks a pivotal moment in Claritev’s strategic transformation journey,” said Travis Dalton, Chairman, CEO and President of Claritev. “With their past industry experience and expertise, Jigar’s and Fernando’s roles will bring us a step closer to providing cutting-edge innovation and technology that promote more affordable, transparent and higher quality healthcare services.
About Claritev
Claritev, formerly known as MultiPlan, is a healthcare technology, data and insights company focused on delivering affordability, transparency and quality to the U.S. healthcare system. Led by a team of deeply experienced associates, data scientists, and innovators, Claritev provides cutting-edge solutions and services fueled by over 40 years of claims processing data. Claritev leverages world-class technology and AI to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency, and optimizes networks and benefits design in healthcare. By developing purpose-build solutions that support all key stakeholders – including payors, employers, patients, providers, and third parties – Claritev is dedicated to making healthcare more accessible and affordable for all.
Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250417495531/en/
Media Relations

Pamela Walker

VP, Marketing & Communication

Claritev

781-895-3118

press@claritev.com



Investor Relations

Jason Wong

SVP, Treasury & Investor Relations

Claritev

866-909-7427

investor@claritev.com



Shawna Gasik

AVP, Investor Relations

Claritev

866-909-7427

investor@claritev.com
Source: Claritev Corporation
© 2020-2025 StockTitan.net
Please enter your login and password
Forgot password?
Don’t have an account? Sign Up!
Please enter your email address
To create a free account, please fill out the form below.
Already have an account? Login

source
This is a newsfeed from leading technology publications. No additional editorial review has been performed before posting.